GSA Capital Partners’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.24M | Buy |
|
|||||
|
2021
Q2 | $1.18M | Buy |
|
|||||
|
2021
Q1 | $590K | Buy |
|
|||||
|
2020
Q4 | $905K | Buy |
|
|||||
|
2020
Q3 | $570K | Buy |
|
|||||
|
2020
Q2 | $173K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $448K | Buy |
|
|||||
|
2019
Q3 | $212K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $903K | Sell |
|
|||||
|
2018
Q4 | $1.18M | Sell |
|
|||||
|
2018
Q3 | $2.54M | Buy |
|
|||||
|
2018
Q2 | $2.08M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.79M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $350K | Sell |
|
|||||
|
2016
Q4 | $579K | Buy |
|
|||||
|
2016
Q3 | $537K | Sell |
|
|||||
|
2016
Q2 | $1.69M | Buy |
|
|||||
|
2016
Q1 | $622K | Sell |
|
|||||
|
2015
Q4 | $1.49M | Buy |
|
|||||
|
2015
Q3 | $1.34M | Buy |
|